Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Chimoday AP 100mg/325mg/50000AU Tablet

Prescription Icon
Prescription Required

Marketer

Atlina Life Sciences (OPC) Pvt Ltd

Salt Composition

Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)

Overview Chimoday AP 100mg/325mg/50000AU Tablet

ArthroPain Relief 100mg/325mg/50000AU tablets offer pain management. This medication treats inflammatory pain associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. It also provides relief from muscle aches, back pain, dental pain, and ear/throat discomfort. Administer ArthroPain Relief with food to minimize stomach upset. Dosage and treatment length are determined by your physician based on your condition and response. Strictly adhere to your doctor's prescribed regimen; avoid exceeding the recommended dose or duration. Common side effects include nausea, vomiting, heartburn, abdominal pain, and dyspepsia. Report any persistent or worsening side effects to your doctor; they may offer strategies for mitigation. Prior to commencing treatment, inform your doctor of any history of stomach ulcers or bleeding, hypertension, or pre-existing heart, kidney, or liver conditions. Disclose all other medications you are currently using to ensure safe interaction. Consult your doctor before using this medication if you are pregnant or breastfeeding. Refrain from alcohol consumption during treatment to avoid excessive sleepiness.

Uses of Chimoday AP 100mg/325mg/50000AU Tablet

Analgesia

Major Benefits of Chimoday AP 100mg/325mg/50000AU Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Chimoday AP 100mg/325mg/50000AU tablets with food.

Common Side effects of Chimoday AP 100mg/325mg/50000AU Tablet:

  • Nausea
  • Vomiting
  • Heartburn
  • Stomach pain
  • Indigestion
  • Loss of appetite
  • Diarrhea

How to use Chimoday AP 100mg/325mg/50000AU Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Chimoday AP 100mg/325mg/50000AU Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Chimoday AP 100mg/325mg/50000AU Tablet works:

Each Chimoday AP 100mg/325mg/50000AU tablet unites aceclofenac, paracetamol, and trypsin-chymotrypsin to alleviate pain. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), and the antipyretic paracetamol, synergistically curb pain and fever by inhibiting the production of inflammatory brain chemicals. Simultaneously, the enzymatic duo, trypsin and chymotrypsin, facilitate protein breakdown, enhancing absorption and improving blood flow to the affected site, thus minimizing inflammation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Chimoday AP 100mg/325mg/50000AU Tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Chimoday AP 100mg/325mg/50000AU Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Chimoday AP 100mg/325mg/50000AU Tablet use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Chimoday AP 100mg/325mg/50000AU Tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Chimoday AP 100mg/325mg/50000AU Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Chimoday AP 100mg/325mg/50000AU Tablets are contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Chimoday AP 100mg/325mg/50000AU Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for individuals with severe or active liver disease.

What if you forget to take Chimoday AP 100mg/325mg/50000AU Tablet :

Should you forget a Chimoday AP 100mg/325mg/50000AU Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Chimoday AP 100mg/325mg/50000AU Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Pain relievers

FAQs on Chimoday AP 100mg/325mg/50000AU Tablet

Aceclofenac, paracetamol, trypsin, and chymotrypsin are combined in Chimoday AP 100mg/325mg/50000AU tablets. This formulation reduces pain and inflammation by lowering the concentration of inflammatory compounds in the body.
Patient addiction to Chimoday AP 100mg/325mg/50000AU Tablets has not been documented.
The medication, Chimoday AP 100mg/325mg/50000AU Tablet, is typically prescribed for brief periods and may be stopped once pain subsides. Nevertheless, continued use is warranted if directed by your physician.
Patients taking Chimoday AP 100mg/325mg/50000AU Tablets may experience dizziness, characterized by lightheadedness, faintness, weakness, or unsteadiness. Should dizziness occur, temporary rest is recommended; activity should resume only after symptoms subside.
Chronic administration of Chimoday AP 100mg/325mg/50000AU Tablets can impair renal function. This is because the kidneys naturally produce prostaglandins, chemicals that protect against kidney damage. Analgesic use diminishes prostaglandin levels, increasing the risk of kidney injury with prolonged consumption. Individuals with pre-existing kidney conditions should avoid using these painkillers.
Chimoday AP 100mg/325mg/50000AU Tablets include paracetamol. Excessive doses can be hepatotoxic. Concomitant alcohol consumption elevates the risk of liver injury. Patients with pre-existing liver conditions should generally abstain from using this medication. Seek immediate medical attention if you experience potential liver damage indicators such as fever, skin eruption, anorexia, emesis, malaise, abdominal discomfort, dark urine, jaundice, or atypical liver function tests.
Pain relief from Chimoday AP 100mg/325mg/50000AU Tablet may become noticeable within approximately one hour of ingestion.
Should you miss a scheduled dose of Chimoday AP 100mg/325mg/50000AU Tablet, and your next dose is imminent, omit the missed dose and continue with your regular dosing schedule. If your next dose is not immediately approaching, take the missed dose as soon as you recall, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one; this could heighten the chance of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increased dosage beyond the prescribed amount won't necessarily enhance effectiveness; instead, it heightens the risk of adverse reactions and potential toxicity. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Patients with documented hypersensitivity to Chimoday AP 100mg/325mg/50000AU Tablet constituents or inactive ingredients should not take this medication. Individuals with a history of peptic ulcers or active gastrointestinal bleeding should generally refrain from using this product. Similarly, its use is contraindicated in patients with a history of cardiac insufficiency, hypertension, or hepatic or renal impairment.
Chimoday AP 100mg/325mg/5...
121
MRP 147
17% off